EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 4 (Avril 2009) Med Sci (Paris), 25 4 (2009) 337-340 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 4, Avril 2009
Page(s) 337 - 340
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2009254337
Published online 15 April 2009
  1. Plum L, Belgardt BF, Bruning JC. Central insulin action in energy and glucose homeostasis. J Clin Invest 2006; 116 : 1761–6. [Google Scholar]
  2. Zhao WQ, Alkon DL. Role of insulin receptor in learning and memory. Mol Cell Endocrinol 2001; 177 : 125–34. [Google Scholar]
  3. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3 : 169–78. [Google Scholar]
  4. Yasuda H, Terada M, Maeda K, et al. Diabetic neuropathy and nerve regenaration. Prog Neurobiol 2003; 69 : 229–85. [Google Scholar]
  5. Abuzzahab MJ, Schneider A, Goddard A, et al. Igf-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349 : 2211–22. [Google Scholar]
  6. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004; 82 : 510–29. [Google Scholar]
  7. Peila R, Rodriguez BI, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia aging study. Diabetes 2002; 51 : 1256–62. [Google Scholar]
  8. Qiu WQ, Walsh DM, Ye Z, et al. Insulin degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998; 273 : 32730–8. [Google Scholar]
  9. Farris W, Mansourian S, Chang Y, et al. Insulin degrading enzyme regulates the levels of insulin, amyloid β-protein, and β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100 : 4162–7. [Google Scholar]
  10. Hu G, Jousilahti P, Bidel S, et al. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care 2007; 30 : 842–7. [Google Scholar]
  11. Dufresne AM, Smith RJ. The adapter protein Grb10 is an endogenous negative regulator of insulin-like growth factor signaling. Endocrinology 2005; 146 : 4399–409. [Google Scholar]
  12. Giovannone B, Lee E, Laviola L, et al. Two novel proteins that are linked to insulin-like growth factor (Igf-I) receptors by the Grb10 adapter and modulate Igf-I signaling. J Biol Chem 2003; 278 : 31564–73. [Google Scholar]
  13. Yoshihashi H, Maeyama K, Kosaki R, et al. Imprinting of human Grb10 and its mutations in two patients with Russell-Silver syndrome. Am J Hum Genet 2000; 67 : 476–82. [Google Scholar]
  14. Lautier C, Goldwurm S, Durr A, et al. Mutations in the Gigyf2 (Tnrc15) gene at the Park11 locus in familial Parkinson disease. Am J Hum Genet 2008; 82 : 822–33. [Google Scholar]
  15. Helmer C, Pasquier F, Dartigues JF. Épidémiologie de la maladie d’Alzheimer et des syndromes apparentés. Med Sci (Paris) 2006; 22 : 288–96. [Google Scholar]
  16. Checler F, Alves da Costa C, Dumanchin-Njock C, et al. Métabolisme du précurseur du peptide amyloïde et présénilines. Med Sci (Paris) 2002; 18 : 717–22. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.